Satellos Bioscience INC F-1 registration statements
The S-1’s counterpart for foreign private issuers registering shares for sale in the United States.
Satellos Bioscience Inc. has filed an amended and restated short form base shelf prospectus to offer up to US$300,000,000 in various securities over a 25-month period.